BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3511664)

  • 1. An ode on the odyssey of lipids.
    Anithasri A
    Biochem Mol Biol Educ; 2024; 52(1):127-128. PubMed ID: 37905739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding HDL Metabolism and Biology Through In Vivo Tracer Kinetics.
    Andraski AB; Sacks FM; Aikawa M; Singh SA
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):76-88. PubMed ID: 38031838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis.
    Li Y; Luo X; Hua Z; Xue X; Wang X; Pang M; Wang T; Lyu A; Liu Y
    Int J Biol Sci; 2023; 19(14):4493-4510. PubMed ID: 37781031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FURTHER STUDIES ON HYPERLIPEMIC ATHEROSCLEROSIS].
    SCHOEN H; BERG G; SCHUERGER W
    Med Welt; 1964 Feb; 8():390-2. PubMed ID: 14136966
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal and extrarenal effects of fibroblast growth factor 23.
    Vervloet M
    Nat Rev Nephrol; 2019 Feb; 15(2):109-120. PubMed ID: 30514976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons.
    Gong JS; Morita SY; Kobayashi M; Handa T; Fujita SC; Yanagisawa K; Michikawa M
    Mol Neurodegener; 2007 May; 2():9. PubMed ID: 17504523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease.
    Haria M; McTavish D
    Drugs; 1997 Feb; 53(2):299-336. PubMed ID: 9028747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol transport through the plasma.
    Myant NB
    Clin Sci (Lond); 1982 Mar; 62(3):261-71. PubMed ID: 6277547
    [No Abstract]   [Full Text] [Related]  

  • 10. Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport.
    Roheim PS
    Am J Cardiol; 1986 Feb; 57(5):3C-10C. PubMed ID: 3511664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein metabolism].
    Corvilain B
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein metabolism].
    Biserte G; Fruchart JC
    Ann Biol Clin (Paris); 1973; 31(2):119-22. PubMed ID: 4356108
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein structure and metabolism.
    Jackson RL; Morrisett JD; Gotto AM
    Physiol Rev; 1976 Apr; 56(2):259-316. PubMed ID: 180553
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the liver in the degradation of lipoproteins.
    Cooper AD
    Gastroenterology; 1985 Jan; 88(1 Pt 1):192-205. PubMed ID: 2981081
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.